Ilseung Cho, MD

Dr. Ilseung Cho is the Assistant Chief Quality Officer for NYU Langone Health and an Associate Professor of Medicine at the NYU School of Medicine. 

As the Assistant Chief Quality Officer, Dr. Cho organizes and leads clinical quality performance measurement, reporting, and improvement activities across NYU Langone Health, with a special focus on hospital-based care. His efforts include the centralized support and leadership of multi-disciplinary efforts that will assess and improve clinical practices affecting all quality dimensions:  effectiveness, safety, timeliness, patient-centeredness, accessibility, and efficiency. His goals are to improve patient outcomes and healthcare delivery through the establishment of integrated and collaborative organization-wide approaches.

Dr. Cho’s research interests focus on the gut microbiome (the community of bacteria that live in the gastrointestinal tract) and how it affects health and disease. Specifically, he focuses on the effect of the colonic microbiome on metabolism as well as in the development of colorectal cancer through epigenetic mechanisms. His research has been published in a variety of journals, including Nature, Cell, FASEB, PLoS ONE, Inflammatory Bowel Disease, Mucosal Immunology, and Nature Reviews Genetics. Dr Cho has contributed to several textbooks, including the current edition of Goldman’s Cecil Medicine, one of the primary textbooks in Internal Medicine. He is the principal or co-investigator on numerous research grants from various organizations including the Doris Duke Foundation and the National Institutes of Health.

Dr. Cho has been featured as an expert commentator for organizations such as CBS, the New York Times, U.S. News and World Report, and National Public Radio.